INKT
Price
$6.98
Change
-$0.47 (-6.31%)
Updated
Jun 27 closing price
Capitalization
27.82M
NKTR
Price
$25.76
Change
-$3.92 (-13.21%)
Updated
Jun 27 closing price
Capitalization
319.6M
40 days until earnings call
Interact to see
Advertisement

INKT vs NKTR

Header iconINKT vs NKTR Comparison
Open Charts INKT vs NKTRBanner chart's image
MiNK Therapeutics
Price$6.98
Change-$0.47 (-6.31%)
Volume$3.47K
Capitalization27.82M
Nektar Therapeutics
Price$25.76
Change-$3.92 (-13.21%)
Volume$4.79M
Capitalization319.6M
INKT vs NKTR Comparison Chart in %
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. NKTR commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Hold and NKTR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (INKT: $6.98 vs. NKTR: $25.76)
Brand notoriety: INKT: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 101% vs. NKTR: 256%
Market capitalization -- INKT: $27.82M vs. NKTR: $319.6M
INKT [@Biotechnology] is valued at $27.82M. NKTR’s [@Biotechnology] market capitalization is $319.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, NKTR is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 2 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • INKT’s TA Score: 2 bullish, 7 bearish.
  • NKTR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а -3.86% price change this week, while NKTR (@Biotechnology) price change was +202.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($320M) has a higher market cap than INKT($27.8M). NKTR YTD gains are higher at: 84.660 vs. INKT (0.158). INKT has higher annual earnings (EBITDA): -9.14M vs. NKTR (-97.97M). NKTR has more cash in the bank: 219M vs. INKT (3.24M). INKT has less debt than NKTR: INKT (5.12M) vs NKTR (100M). NKTR has higher revenues than INKT: NKTR (87.2M) vs INKT (0).
INKTNKTRINKT / NKTR
Capitalization27.8M320M9%
EBITDA-9.14M-97.97M9%
Gain YTD0.15884.6600%
P/E RatioN/AN/A-
Revenue087.2M-
Total Cash3.24M219M1%
Total Debt5.12M100M5%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INKTNKTR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPGY34.610.49
+1.44%
Compass Group Plc
FOLGF0.10N/A
N/A
Falcon Oil & Gas Ltd.
HTCMY59.31N/A
N/A
Hitachi Construction Machinery Co., Ltd.
SZGPY2.38N/A
N/A
Salzgitter AG
SVUHF0.08N/A
-1.20%
SRIVARU Holding Limited

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-6.31%
RAIN - INKT
44%
Loosely correlated
+5.79%
LPTX - INKT
42%
Loosely correlated
-6.47%
CADL - INKT
34%
Loosely correlated
N/A
SABS - INKT
29%
Poorly correlated
-5.06%
NKTR - INKT
28%
Poorly correlated
-13.21%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-13.21%
CRNX - NKTR
43%
Loosely correlated
-1.48%
XNCR - NKTR
41%
Loosely correlated
-3.10%
YMAB - NKTR
41%
Loosely correlated
-2.08%
ABCL - NKTR
40%
Loosely correlated
-3.48%
ATOS - NKTR
40%
Loosely correlated
+0.24%
More